Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
The Journal of Infection|May 2, 2021
Recent advances in meningococcal B disease prevention: real-world evidence from 4CMenB vaccinationFederico Martinón-Torres, Angelika Banzhoff, Chiara Azzari, et al.Annals of Medicine|January 9, 2018
Maternal immunization: where are we now and how to move forward?Ivo Vojtek, Ilse Dieussaert, T Mark Doherty, et al.The Pediatric Infectious Disease Journal|October 16, 2020
Four-component Meningococcal Serogroup B Vaccine Induces Antibodies With Bactericidal Activity Against Diverse Outbreak Strains in AdolescentsAlessia Biolchi, Sara Tomei, Laura Santini, et al.Expert Review of Vaccines|June 6, 2023
A comprehensive review of clinical and real-world safety data for the four-component serogroup B meningococcal vaccine (4CMenB)Gary S Marshall, Victoria Abbing-Karahagopian, Helen S Marshall, et al.Journal of the Pediatric Infectious Diseases Society|November 15, 2019
Evaluation of a New Clinical Endpoint for Moderate to Severe Influenza Disease in Children: A Prospective Cohort StudySuchitra Rao, Emad Yanni, Angela Moss, et al.Human Vaccines & Immunotherapeutics|October 25, 2019
Assessing direct and indirect effects of pediatric influenza vaccination in Germany by individual-based simulationsRuprecht Schmidt-Ott, Daniel Molnar, Anastassia Anastassopoulou, et al.Expert Review of Vaccines|March 10, 2022
Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal diseaseMuhamed-Kheir Taha, Federico Martinon-Torres, Ralph Köllges, et al.Human Vaccines & Immunotherapeutics|February 21, 2020
Retrospective study of the use of an influenza disease two-tiered classification system to characterize clinical severity in US childrenAmber Hsiao, Philip O Buck, Arnold Yee, et al.Vaccine|April 30, 2019
Safety of AS03-adjuvanted influenza vaccines: A review of the evidenceCatherine Cohet, Robbert van der Most, Vincent Bauchau, et al.Vaccine|August 19, 2020
Modelling the impact of 4CMenB and MenACWY meningococcal combined vaccination strategies including potential 4CMenB cross-protection: An application to EnglandEkkehard Beck, Johan Klint, Stephanie Garcia, et al.Pageof 4